Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Fibrocell and Hefei Meifu Announce JV

publication date: Nov 5, 2010
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Fibrocell Science, Inc. will set up a joint venture with Hefei Meifu Bio-Tech Limited, centered on developing its autologous fibroblast therapies for aesthetic use in Asia, excluding Japan. Fibrocell will contribute its fibroblast IP, clinical data and manufacturing processes. Meifu will build a manufacturing facility in Hefei and be responsible for commercialization and marketing. Further financial details were not disclosed. More details....

Stock Symbol: (OTCBB: FCSC)

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...